PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 17 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Oral administration of C. grevei extract in rats prevented the increase of systolic blood pressure (SBP) in aged rats and induced a progressive decrease in SBP in normotensive rats [PMID: 18325702, PMID: 14551050]
Methanolic extract of C. grevei leaves demonstrated antioxidant and hepatoprotective effects against cypermethrin-induced oxidative stress and liver damage in male mice [PMID: 26209317]
Leaf essential oil showed cytotoxic activity against human breast cancer cells (IC50=21.5 mg/L) [PMID: 23459148]
Leaf essential oil showed antimalarial activity (IC50=17.5mg/L) [PMID: 23459148]
Leaf essential oil exhibited antiinflammatory activity (IC50=21.33 mg/L) [PMID: 23459148]
Evidence summary
PubMed sources
- 1.PMID: 36364121 (2022) — Beyond the Bark: An Overview of the Chemistry and Biological Activities of Selected Bark Essential Oils. · Molecules (Basel, Switzerland)
- 2.PMID: 24591320 (2014) — Bark essential oil of Cedrelopsis grevei from Madagascar: investigation of steam-distillation conditions. · Chemistry & biodiversity
- 3.PMID: 14630167 (2003) — New coumarins from Cedrelopsis grevei. · Fitoterapia
- 4.PMID: 12453517 (2002) — Coumarins from Cedrelopsis grevei (Ptaeroxylaceae). · Phytochemistry
- 5.PMID: 18325702 (2008) — Cedrelopsis grevei improves endothelial vasodilatation in aged rats through an increase of NO participation.